Format

Send to

Choose Destination
J Law Med Ethics. 2018 Jun;46(2):552-554. doi: 10.1177/1073110518782970.

Defining "True and Non-Misleading" for Pharmaceutical Promotion.

Author information

1
Spencer Phillips Hey, Ph.D., is a Research Scientist in the Program on Regulation, Therapeutics, and Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women's Hospital and a faculty member at the Harvard Center for Bioethics in Boston. Aaron S. Kesselheim, M.D., J.D., M.P.H., is an Associate Professor of Medicine at Harvard Medical School and Director of the Program on Regulation, Therapeutics, and Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women's Hospital and a faculty member at the Harvard Center for Bioethics in Boston. He is also a faculty member at the Harvard Center for Bioethics.
PMID:
30146990
DOI:
10.1177/1073110518782970

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center